The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Acad Dermatol
Auteurs principaux: Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.
Format: Artigo
Langue:Inglês
Publié: by the American Academy of Dermatology, Inc. 2020
Sujets:
Research Letter
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235584/
https://ncbi.nlm.nih.gov/pubmed/32416207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.05.035
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires